Fund Holdings — venBio Partners LLC

Total Portfolio Value
$280.55M
Total Bought
$14.87M
Total Sold
$55.31M
Net Transaction
-$40.44M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ALUMIS INC4,619,8034,528,408-91,39545,08999,76135.56%+54,672
ALX ONCOLOGY HLDGS INC(ALXO)9,699,92512,884,638+3,184,71310,96125,8349.21%+14,873
PHARVARIS N V
COM
4,639,3044,639,3040128,741131,06046.71%+2,320
ARTIVA BIOTHERAPEUTICS INC(ARTV)648,507531,337-117,1702,7823,4221.22%+640
LYELL IMMUNOPHARMA INC(LYEL)337,697337,697010,3946,7742.41%-3,620
HARMONY BIOSCIENCES HLDGS IN(HRMY)489,194489,194018,30613,7024.88%-4,603
Page 1 of 1
venBio Partners LLC — 13F Holdings — Q1 2026 | TickerTrail